Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Keywords:
Liposome
PD-L1
Doxorubicin
Chemo-immunotherapy
Immunotherapy
Immunogenic cell death
Melanoma
Immunocheckpoint
Note:
This article is licensed under a Creative Commons Attribution 4.0 International License
Citation:
Merino-Díaz, M. (María); Lozano-Moreda, T. (Teresa); Casares-Lagar, I. (Inés Noelia); et al. "Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model". Journal of Nanobiotechnology. 19 (1), 2021, 102
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.